Show simple item record

dc.contributor.authorBaxter-Holland, M.
dc.contributor.authorDass, Crispin
dc.date.accessioned2018-12-13T09:16:08Z
dc.date.available2018-12-13T09:16:08Z
dc.date.created2018-12-12T02:46:29Z
dc.date.issued2018
dc.identifier.citationBaxter-Holland, M. and Dass, C. 2018. Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy. Journal of Pharmacy and Pharmacology. 70 (9): pp. 1127-1138.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/73327
dc.identifier.doi10.1111/jphp.12942
dc.description.abstract

© 2018 Royal Pharmaceutical Society Objectives: Pigment epithelium-derived factor (PEDF), a multifunctional endogenous glycoprotein, has a very wide range of biological actions, notably in bone homeostasis. The question has been raised regarding the place of PEDF in the treatment of bone disorders and osteosarcoma, and its potential for tumour growth suppression. Methods: The PubMed database was used to compile this review. Key findings: Pigment epithelium-derived factor's actions in osteoid tissues include promoting mesenchymal stem cell commitment to osteoblasts, increasing matrix mineralisation, and promoting osteoblast proliferation. It shows potential to improve therapeutic outcomes in treatment of multiple cancer types and regrowth of bone after trauma or resection in animal studies. PEDF may possibly have a reduced adverse effect profile compared with current osteo-regenerative treatments; however, there is currently very limited evidence regarding the safety or efficacy in human models. Summary: Pigment epithelium-derived factor is very active within the body, particularly in osseous tissue, and its physiological actions give it potential for treatment of both bone disorders and multiple tumour types. Further research is needed to ascertain the adverse effects and safety profile of PEDF as a therapeutic agent.

dc.publisherJohn Wiley & Sons Ltd.
dc.titlePigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
dc.typeJournal Article
dcterms.source.volume70
dcterms.source.number9
dcterms.source.startPage1127
dcterms.source.endPage1138
dcterms.source.issn0022-3573
dcterms.source.titleJournal of Pharmacy and Pharmacology
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record